Companion nosology is employed to establish who would have the benefit of treatment and it comes in handy to identify if somebody cannot be cured, however additionally conversely is injured by the employment of a selected drug used for his or her ill. Technological advancements have brought a lot of changes within the technique of illness treatment. Companion nosology is characterised by growing demand for increased personal patient treatment that provides aid suppliers and their patients an assurance concerning the treatment lead to a positive method, contrary to ancient treatment procedure. Major impact of companion diagnostic is on medical specialty medical care space.
How Big is The Global Companion Diagnostics Market?
The Companion Diagnostics Market is expected to be around US$ 14.5 Billion by 2028 at a CAGR of 20% in the given forecast period.
The major driving factors of Companion Diagnostics Market are as follows:
The major restraining factors of Companion Diagnostics Market are as follows:
The Companion Diagnostics Market has been segmented as below:
By Indication:
By Technology:
The Companion Diagnostics Market is segmented on the lines of its Indication, Technology and regional. Basis of Indication is segmented into Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Urology and Gastric Cancer. Based on technology it covers Immunohistochemistry, Molecular Diagnostics, In-situ Hybridization, FISH, CISH, Real Time PCR and Gene Sequencing. The Companion Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Companion Diagnostics Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Companion Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of Companion Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Dako (Agilent Technologies), Roche Holdings, Qiagen NV, Seimens Helthineers, Takeda Pharmaceuticals, Myriad Genetics, Thermo Fisher Scientific, Tacogen, and Illumina Inc., among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Companion Diagnostics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Companion Diagnostics Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Haemodialysis and Peritoneal Dialysis Market
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Report Summary
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restrains
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Companion Diagnostics Market Analysis, By Indication
5.1 Colorectal Cancer
5.2 Breast Cancer
5.3 Lung Cancer
5.4 Melanoma
5.5 Urology
5.6 Gastric Cancer
6. Companion Diagnostics Market Analysis, By Technology
6.1 Immunohistochemistry
6.2 Molecular Diagnostics
6.3 In-situ Hybridization
6.4 FISH
6.5 CISH
6.6 Real Time PCR
6.7 Gene Sequencing
7. Companion Diagnostics Market Analysis, By Region
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of the World
8. Competitive Overview
8.1 Introduction
8.2 New Product Launches
8.3 Acquisitions
8.4 Agreements, Partnerships, And Collaborations
8.5 Expansions
9. Company Profiles
9.1 Seimens Healthineers
9.2 Roche Holdings
9.3 Abbott Laboratories
9.4 Dako (Agilent Technologies)
9.5 Qiagen NV
9.6 Illumina Inc.
9.7 Takeda Pharmaceuticals
9.8 Thermo Fisher Scientific
9.9 Tacogen
9.10 Myriad Genetics
9.11 Others
The Companion Diagnostics Market has been segmented as below:
By Indication:
By Technology:
By Regional Analysis:
